Enter to open, tab to navigate, enter to select
Ra Pharmaceuticals, Inc. IPO underwriting agreement
| October 25, 2016 • Underwriting Agreements • $91,639,990 |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.